CVRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $1.55

Piyasa Değeri (MRQ) $41M

P/E (TTM) -0.8

Hisse Başına Kâr (TTM) $-1.97

Gelir (TTM) $61M

ROE (TTM) -133.4%

D/E Borç/Özsermaye (MRQ) 2.9

52 Haftlık Aralık $2–$11

CVRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

CVRx, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealth Care endüstriHealth Care çalışanlar223 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$57M

2020-12-31 → 2025-12-31

Hisse Başına Kâr$-2.04

2021-12-31 → 2025-12-31

Serbest Nakit Akışı$-41M

2021-12-31 → 2025-12-31

Net kar marjı-84.9%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-0.85Y ort. ≈-7.2	≈-7.2	·	·
F/S (TTM)	0.75Y ort. ≈12.4	≈12.4	2.2	Adil değer
F/D (MRQ)	2.15Y ort. ≈4.6	≈4.6	3.8	Aşırı değerli
EV / EBITDA	-0.35Y ort. ≈-6.4	≈-6.4	·	·
Fiyat / Serbest Nakit Akışı (TTM)	-1.05Y ort. ≈-9.3	≈-9.3	·	·
Fiyat / Nakit Akışı (TTM)	-1.05Y ort. ≈-9.5	≈-9.5	·	·
EV / Revenue (EV / Gelir)	0.35Y ort. ≈8.8	≈8.8	·	·
EV / FCF	-0.45Y ort. ≈-7.1	≈-7.1	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	1.05Y ort. ≈4.6	≈4.6	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
Brüt Kar Marjı (TTM)	86.9%5Y ort. ≈80.6%	≈80.6%	37.9%	En üst düzey
Faaliyet Kâr Marjı (TTM)	-79.5%5Y ort. ≈-140.9%	≈-140.9%	-18.1%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-90.5%5Y ort. ≈-140.9%	≈-140.9%	-17.5%	Zayıf
Vergi Öncesi Kar Marjı (TTM)	-84.9%5Y ort. ≈-165.8%	≈-165.8%	-11.6%	Zayıf
Net Kâr Marjı (TTM)	-84.9%5Y ort. ≈-166.1%	≈-166.1%	-50.8%	Ortalamanın altında
ROA (TTM)	-49.1%5Y ort. ≈-39.4%	≈-39.4%	-13.7%	Zayıf
ROE (TTM)	-133.4%5Y ort. ≈-62.9%	≈-62.9%	-81.1%	Zayıf
ROIC	-57.7%5Y ort. ≈-40.6%	≈-40.6%	-16.7%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
Borç / Öz Sermaye (MRQ)	2.95Y ort. ≈0.5	≈0.5	1.8	Ortalamanın üstünde
Cari Oran (MRQ)	8.05Y ort. ≈14.9	≈14.9	2.7	Güçlü likidite
Quick Ratio (Cari Oran)	6.55Y ort. ≈13.6	≈13.6	1.9	Güçlü likidite
Uzun Vadeli Borç / Özkaynak (MRQ)	2.95Y ort. ≈0.5	≈0.5	2.9	Aynı seviyede

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	10.4%5Y ort. ≈60.7%	≈60.7%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	36.1%5Y ort. ≈60.2%	≈60.2%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	56.4%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-2.045Y ort. ≈$-2.57	≈$-2.57	·	·
Revenue / Share (Hisse Başına Gelir)	$2.175Y ort. ≈$1.86	≈$1.86	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-1.545Y ort. ≈$-1.81	≈$-1.81	·	·
Cash / Share (Hisse Başına Nakit)	$2.885Y ort. ≈$4.70	≈$4.70	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	CVRX	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.55Y ort. ≈0.3	≈0.3	0.7	Zayıf
Inventory Turnover (Stok Devir Hızı)	0.75Y ort. ≈0.8	≈0.8	2.3	Zayıf
Receivables Turnover (Alacak Devir Hızı)	5.75Y ort. ≈6.0	≈6.0	5.8	Aynı seviyede
Revenue / Employee (Çalışan Başına Gelir)	≈$254.0K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 1.1%

Sonraki Rapor Kas 03, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 3, 2026	$-0.53	$-0.53	0.90%
31 Mart 2026		$-0.50	$-0.51	2.8%
31 Aralık 2025		$-0.46	$-0.45	-2.8%
30 Eylül 2025		$-0.49	$-0.51	4.2%
30 Haziran 2025		$-0.57	$-0.53	-7.5%
31 Mart 2025		$-0.53	$-0.58	8.8%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 17

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$57M	$51M	$39M	$22M	$13M	$6M
Cost of Revenue	$8M	$8M	$6M	$5M	$4M	$1M
Gross Profit	$48M	$43M	$33M	$17M	$9M	$5M
R&D Expense	$11M	$11M	$12M	$10M	$8M	$6M
SG&A Expense	$88M	$91M	$65M	$50M	$28M	$10M
Operating Expenses	$100M	$102M	$76M	$60M	$35M	$16M
Operating Income	$-51M	$-59M	$-43M	$-43M	$-26M	$-12M
Interest Expense	·	·	$2M	$165.0K	$2M	$2M
Other Non-op	$4M	$4M	$4M	$1M	$-15M	$-40.0K
Pretax Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
Income Tax	$-18.0K	$55.0K	$147.0K	$109.0K	$91.0K	$85.0K
Net Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
EPS (Basic)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
EPS (Diluted)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
Shares (Basic)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
Shares (Diluted)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
EBITDA	$-51M	$-59M	$-43M	$-43M	$-26M	·

Bilanço 24

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$76M	$106M	$91M	$106M	$142M	$59M
Receivables	$11M	$9M	$8M	$6M	$3M	$1M
Inventory	$12M	$12M	$11M	$7M	$4M	$3M
Prepaid Expense	$3M	$3M	$3M	$4M	$3M	$605.0K
Current Assets	$102M	$130M	$112M	$123M	$151M	$64M
PP&E (Net)	$2M	$3M	$2M	$2M	$1M	$410.0K
PP&E (Gross)	$6M	$6M	$5M	$4M	$3M	$2M
Accum. Depreciation	$4M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K	$26.0K
Total Assets	$105M	$133M	$115M	$125M	$153M	$65M
Accounts Payable	$4M	$3M	$2M	$2M	$510.0K	$483.0K
Accrued Liabilities	$9M	$8M	$6M	$6M	$5M	$4M
Current Liabilities	$13M	$11M	$8M	$8M	$6M	$8M
Capital Leases	$638.0K	$877.0K	$1M	$117.0K	$0	·
Other Non-current Liabilities	$2M	$1M	$1M	$805.0K	$681.0K	$777.0K
Total Liabilities	$65M	$62M	$39M	$16M	$7M	$28M
Long-term Debt	·	·	·	·	·	$19M
Total Debt	$50M	$49M	$29M	$7M	$0	·
Common Stock	$263.0K	$253.0K	$209.0K	$207.0K	$204.0K	$4.0K
Retained Earnings	$-591M	$-537M	$-477M	$-436M	$-395M	$-352M
AOCI	$-203.0K	$-206.0K	$-207.0K	$-207.0K	$-198.0K	$-190.0K
Stockholders' Equity	$39M	$71M	$76M	$109M	$146M	$-293M
Liabilities + Equity	$105M	$133M	$115M	$125M	$153M	$65M
Shares Outstanding	26,311,607	25,324,684	20,879,199	20,663,736	20,399,337	360,412

Nakit Akışı 11

Metrik	2025	2024	2023	2022	2021	2020
Stock-based Comp	$11M	$19M	$6M	$4M	$2M	$132.0K
Operating Cash Flow	$-40M	$-39M	$-39M	$-43M	$-28M	$-16M
CapEx	$580.0K	$1M	$591.0K	$685.0K	$1M	$311.0K
Investing Cash Flow	$-580.0K	$-1M	$-591.0K	$-685.0K	$-1M	$-311.0K
Net Debt Issued	·	·	·	$0	$-21M	·
Stock Issued	$9M	$33M	$0	$0	$133M	$0
Net Stock Activity	$9M	$33M	·	$0	$133M	·
Financing Cash Flow	$11M	$56M	$24M	$7M	$112M	$50M
Net Change in Cash	$-30M	$15M	$-16M	$-36M	$83M	$33M
Free Cash Flow	$-41M	$-41M	$-40M	$-43M	$-29M	·
Levered FCF	·	·	$-41M	$-44M	$-31M	·

Kârlılık 8

Metrik	2025	2024	2023	2022	2021	2020
Gross Margin	85.3%	83.8%	84.1%	77.8%	72.1%	·
Operating Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
Net Margin	-94.1%	-116.9%	-104.8%	-184.4%	-330.4%	·
Pretax Margin	-94.1%	-116.8%	-104.5%	-183.9%	-329.8%	·
EBITDA Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
ROA	-44.8%	-48.2%	-34.3%	-29.9%	-39.6%	·
ROE	-109.6%	-88.0%	-51.9%	-36.4%	-28.5%	·
ROIC	-57.7%	-49.5%	-41.1%	-36.8%	-17.8%	·

Likidite ve Solventlik 5

Metrik	2025	2024	2023	2022	2021	2020
Current Ratio	7.6	12.1	14.3	15.2	25.6	·
Quick Ratio	6.5	10.7	12.5	13.8	24.5	·
Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
LT Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
Interest Coverage	·	·	-24.0	-257.7	-11.7	·

Verimlilik 3

Metrik	2025	2024	2023	2022	2021	2020
Asset Turnover	0.5	0.4	0.3	0.2	0.1	·
Inventory Turnover	0.7	0.7	0.7	0.9	1.0	·
Receivables Turnover	5.7	6.1	6.0	5.6	6.8	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.49	$2.81	$3.64	$5.29	$7.16	·
Revenue / Share	$2.17	$2.27	$1.89	$1.09	·	·
Cash Flow / Share	$-1.54	$-1.73	$-1.88	$-2.08	·	·
Cash / Share	$2.88	$4.18	$4.34	$5.15	$6.96	·
EPS (TTM)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020
Revenue YoY	10.4%	30.5%	74.9%	72.4%	115.4%	·
Revenue CAGR 3Y	36.1%	57.9%	86.6%	·	·	·
Revenue CAGR 5Y	56.4%	·	·	·	·	·

Değerleme (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$57M	$51M	$39M	$22M	$13M	·
Net Income TTM	$-53M	$-60M	$-41M	$-41M	$-43M	·
Market Cap	$187M	$321M	$656M	$379M	$249M	·
Enterprise Value	$161M	$264M	$595M	$279M	$107M	·
P/E	-3.5	-4.8	-15.8	-9.1	-2.9	·
P/S	3.3	6.3	16.7	16.9	19.1	·
P/B	4.8	4.5	8.6	3.5	1.7	·
P / Tangible Book	4.8	4.5	8.6	3.5	1.7	·
P / Cash Flow	-4.7	-8.2	-16.8	-8.9	-9.0	·
P / FCF	-4.6	-7.9	-16.6	-8.7	-8.6	·
EV / EBITDA	-3.1	-4.4	-13.8	-6.6	-4.1	·
EV / FCF	-3.9	-6.5	-15.0	-6.4	-3.7	·
EV / Revenue	2.8	5.2	15.1	12.4	8.2	·
Earnings Yield	-28.7%	-20.9%	-6.3%	-11.0%	-34.0%	·

Gelir Tablosu 17

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$16M	$15M	$16M	$15M	$14M	$12M	$15M	$13M	$12M	$11M	$11M	$11M	$10M	$8M	$7M	$6M
Cost of Revenue	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$2M	$1M
Gross Profit	$14M	$13M	$14M	$13M	$11M	$10M	$13M	$11M	$10M	$9M	$10M	$9M	$8M	$7M	$6M	$5M
R&D Expense	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$2M
SG&A Expense	$24M	$22M	$22M	$22M	$23M	$21M	$20M	$22M	$21M	$28M	$17M	$16M	$16M	$15M	$14M	$13M
Operating Expenses	$27M	$25M	$25M	$25M	$26M	$24M	$23M	$24M	$24M	$31M	$19M	$18M	$20M	$19M	$17M	$15M
Operating Income	$-13M	$-12M	$-11M	$-12M	$-14M	$-13M	$-10M	$-13M	$-14M	$-22M	$-10M	$-10M	$-12M	$-12M	$-11M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	$960.0K	·	$499.0K	$481.0K	$240.0K	$165.0K	$0
Other Non-op	$560.0K	$593.0K	$660.0K	$875.0K	$1M	$1M	$1M	$917.0K	$944.0K	$1M	$1M	$1M	$616.0K	$1M	$1M	$328.0K
Pretax Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
Income Tax	$3.0K	$1.0K	$-7.0K	$-3.0K	$-3.0K	$-5.0K	$-71.0K	$47.0K	$41.0K	$38.0K	$39.0K	$40.0K	$34.0K	$34.0K	$28.0K	$32.0K
Net Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
EPS (Basic)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
EPS (Diluted)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
Shares (Basic)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
Shares (Diluted)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
EBITDA	$-13M	$-12M	·	$-12M	$-14M	$-13M	·	$-13M	$-14M	$-22M	·	$-10M	$-12M	$-12M	·	$-10M

Bilanço 23

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$65M	$72M	$76M	$85M	$95M	$103M	$106M	$100M	$70M	$80M	$91M	$83M	$91M	$103M	$106M	$110M
Receivables	$9M	$9M	$11M	$8M	$7M	$9M	$9M	$9M	$9M	$8M	$8M	$6M	$7M	$6M	$6M	$5M
Inventory	$13M	$12M	$12M	$11M	$12M	$12M	$12M	$12M	$11M	$11M	$11M	$11M	$11M	$8M	$7M	$6M
Prepaid Expense	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$4M	$3M	$4M	$3M
Current Assets	$89M	$97M	$102M	$108M	$116M	$126M	$130M	$124M	$92M	$102M	$112M	$104M	$112M	$121M	$123M	$124M
PP&E (Net)	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M
PP&E (Gross)	$5M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M	$4M	$4M	$4M	$4M	$4M
Accum. Depreciation	$3M	$3M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K
Total Assets	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Accounts Payable	$4M	$3M	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$3M	$2M	$1M	$3M	$2M	$2M	$1M
Accrued Liabilities	$7M	$6M	$9M	$8M	$7M	$6M	$8M	$8M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M
Current Liabilities	$11M	$9M	$13M	$11M	$10M	$9M	$11M	$11M	$9M	$8M	$8M	$7M	$9M	$8M	$8M	$7M
Capital Leases	$448.0K	$544.0K	$638.0K	$730.0K	$819.0K	$802.0K	$877.0K	$951.0K	$1M	$1M	$1M	$916.0K	$946.0K	$59.0K	$117.0K	$175.0K
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$960.0K	$885.0K	$815.0K	$805.0K	$761.0K
Total Liabilities	$72M	$71M	$65M	$63M	$62M	$60M	$62M	$62M	$41M	$40M	$39M	$24M	$25M	$23M	$16M	$8M
Total Debt	$59M	$58M	·	$49M	$49M	$49M	·	$49M	$29M	$29M	·	$14M	$14M	$14M	·	·
Common Stock	$266.0K	$264.0K	$263.0K	$262.0K	$261.0K	$261.0K	$253.0K	$242.0K	$217.0K	$216.0K	$209.0K	$208.0K	$208.0K	$207.0K	$207.0K	$206.0K
Retained Earnings	$-618M	$-604M	$-591M	$-579M	$-566M	$-551M	$-537M	$-527M	$-514M	$-500M	$-477M	$-468M	$-459M	$-448M	$-436M	$-426M
AOCI	$-204.0K	$-203.0K	$-203.0K	$-204.0K	$-203.0K	$-205.0K	$-206.0K	$-208.0K	$-210.0K	$-210.0K	$-207.0K	$-208.0K	$-187.0K	$-204.0K	$-207.0K	$-219.0K
Stockholders' Equity	$20M	$29M	$39M	$48M	$58M	$69M	$71M	$65M	$55M	$66M	$76M	$83M	$90M	$100M	$109M	$118M
Liabilities + Equity	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Shares Outstanding	26,641,597	26,428,767	26,311,607	26,193,733	26,145,951	26,051,992	25,324,684	24,203,658	21,712,357	21,593,173	20,879,199	20,813,612	20,750,910	20,708,940	20,663,736	20,578,963

Nakit Akışı 10

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$4M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$11M	$2M	$2M	$1M	$2M	$1M	$929.0K
Operating Cash Flow	$-9M	$-12M	$-10M	$-10M	$-8M	$-13M	$-8M	$-10M	$-10M	$-11M	$-8M	$-8M	$-13M	$-10M	$-11M	$-11M
CapEx	$112.0K	$122.0K	$68.0K	$295.0K	$103.0K	$114.0K	$52.0K	$37.0K	$355.0K	$917.0K	$169.0K	$39.0K	$143.0K	$240.0K	$79.0K	$264.0K
Investing Cash Flow	$-112.0K	$-122.0K	$-68.0K	$-295.0K	$-103.0K	$-114.0K	$-52.0K	$-37.0K	$-355.0K	$-917.0K	$-169.0K	$-39.0K	$-143.0K	$-240.0K	$-79.0K	$-264.0K
Stock Issued	$739.0K	$-43.0K	$-179.0K	$-45.0K	$0	$9M	$12M	$20M	$-1.0K	$547.0K	$0	$0	$0	$0	·	·
Net Stock Activity	·	$-43.0K	·	·	·	$9M	·	·	·	$547.0K	·	·	·	·	·	·
Financing Cash Flow	$1M	$9M	$410.0K	$103.0K	$392.0K	$10M	$14M	$40M	$472.0K	$1M	$16M	$363.0K	$473.0K	$8M	$7M	$7.0K
Net Change in Cash	$-8M	$-3M	$-9M	$-10M	$-8M	$-3M	$6M	$30M	$-10M	$-10M	$8M	$-8M	$-12M	$-3M	$-4M	$-11M
Free Cash Flow	·	$-12M	·	·	·	$-13M	·	·	·	$-12M	·	·	·	$-10M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$-11M	·	·

Kârlılık 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	87.4%	87.2%	·	86.8%	84.3%	83.5%	·	83.2%	83.9%	85.0%	·	83.9%	84.0%	83.4%	·	78.3%
Operating Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
Net Margin	-89.4%	-88.8%	·	-87.6%	-108.4%	-111.5%	·	-98.0%	-118.8%	-206.0%	·	-85.7%	-122.6%	-142.6%	·	-158.9%
Pretax Margin	-89.4%	-88.8%	·	-87.6%	-108.5%	-111.5%	·	-97.6%	-118.5%	-205.7%	·	-85.4%	-122.3%	-142.1%	·	-158.4%
EBITDA Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
ROA	-13.3%	-11.4%	·	-10.8%	-13.7%	-11.7%	·	-11.2%	-13.3%	-19.4%	·	-7.7%	-9.4%	-8.5%	·	-6.4%
ROE	-36.1%	-26.7%	·	-22.7%	-26.0%	-20.3%	·	-17.7%	-19.3%	-26.8%	·	-9.0%	-10.7%	-9.6%	·	-7.2%
ROIC	-16.6%	-13.9%	·	-12.6%	-13.4%	-11.3%	·	-11.4%	-16.6%	-23.3%	·	-9.8%	-11.3%	-10.7%	·	-8.6%

Likidite ve Solventlik 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	8.0	10.2	·	9.6	12.0	14.8	·	11.3	10.1	12.2	·	14.0	12.6	15.2	·	16.8
Quick Ratio	6.7	8.6	·	8.3	10.5	13.1	·	10.0	8.7	10.6	·	12.1	10.9	13.8	·	15.6
Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
LT Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-23.2	·	-19.1	-24.4	-50.7	·	·

Verimlilik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.0
Inventory Turnover	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.3
Receivables Turnover	1.9	1.6	·	1.7	1.7	1.4	·	1.7	1.5	1.4	·	1.8	1.8	1.6	·	1.4

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.75	$1.10	·	$1.83	$2.22	$2.66	·	$2.69	$2.54	$3.07	·	$3.98	$4.34	$4.81	·	$5.75
Revenue / Share	$0.59	$0.56	·	$0.56	$0.52	$0.48	·	$0.59	$0.55	$0.51	·	$0.51	$0.46	$0.39	·	$0.30
Cash Flow / Share	·	$-0.46	·	·	·	$-0.49	·	·	·	$-0.51	·	·	·	$-0.50	·	·
Cash / Share	$2.42	$2.74	·	$3.25	$3.63	$3.94	·	$4.14	$3.24	$3.71	·	$3.99	$4.38	$4.99	·	$5.34
EPS (TTM)	$-1.97	$-2.01	·	$-1.98	$-2.06	$-2.14	·	$-2.71	$-2.57	$-2.48	·	$-2.05	$-2.10	$-2.08	·	$67.03

Değerleme (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$61M	$59M	·	$56M	$55M	$53M	·	$47M	$44M	$42M	·	$35M	$31M	$26M	·	$19M
Net Income TTM	$-52M	$-53M	·	$-52M	$-52M	$-52M	·	$-58M	$-54M	$-52M	·	$-43M	$-43M	$-43M	·	$-41M
Market Cap	$137M	$250M	·	$211M	$154M	$319M	·	$213M	$260M	$393M	·	$316M	$320M	$193M	·	$192M
Enterprise Value	$131M	$236M	·	$176M	$108M	$265M	·	$162M	$219M	$342M	·	$247M	$244M	$104M	·	·
P/E	-2.6	-4.7	·	-4.1	-2.9	-5.7	·	-3.3	-4.7	-7.3	·	-7.4	-7.4	-4.5	·	0.1
P/S	2.2	4.2	·	3.8	2.8	6.0	·	4.5	5.9	9.3	·	9.0	10.4	7.3	·	10.1
P/B	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Tangible Book	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Cash Flow	·	-20.6	·	·	·	-25.0	·	·	·	-36.1	·	·	·	-18.8	·	·
EV / Revenue	2.1	4.0	·	3.1	2.0	5.0	·	3.4	4.9	8.1	·	7.0	7.9	3.9	·	·
Earnings Yield	-38.3%	-21.2%	·	-24.5%	-35.0%	-17.5%	·	-30.8%	-21.4%	-13.6%	·	-13.5%	-13.6%	-22.3%	·	718.4%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$57M	$51M	$39M	$22M	$13M
Brüt Kâr Marjı %	85.3%	83.8%	84.1%	77.8%	72.1%
Faaliyet Kâr Marjı %	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%
Net Gelir	$-53M	$-60M	$-41M	$-41M	$-43M
Seyreltilmiş Hisse Başı Kâr	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	1.3	0.7	0.4	0.1	0.0
Cari Oran	7.6	12.1	14.3	15.2	25.6
Cari Oran	6.5	10.7	12.5	13.8	24.5

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-41M	$-41M	$-40M	$-43M	$-29M

Kurumsal Sahipler (13F) 95 dosya · $87.3M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 95

Tutulan Değer $87.3M

Yeni pozisyonlar 8

Çıkan pozisyonlar 18

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
8 (-19 önceki Ç'ye göre)	18 (+5 önceki Ç'ye göre)	35 (+2 önceki Ç'ye göre)	29 (+9 önceki Ç'ye göre)	+574K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
JOHNSON & JOHNSON	$20.687.786	4.024.861	23,70%	Hisse senetleri
NEA Management Company, LLC	$10.045.822	1.954.440	11,51%	Hisse senetleri
VANGUARD GROUP INC	$7.956.707	1.120.663	9,12%	Hisse senetleri
BlackRock, Inc.	$6.401.661	1.245.459	7,33%	Hisse senetleri
ROYAL BANK OF CANADA	$6.338.000	1.233.212	7,26%	Hisse senetleri
GSK plc	$5.178.977	1.007.583	5,93%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$4.680.361	910.576	5,36%	Hisse senetleri
SILVERCREST ASSET MANAGEMENT GROUP LLC	$4.513.480	878.109	5,17%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$2.266.478	440.786	2,60%	Hisse senetleri
PFM Health Sciences, LP	$1.899.600	369.572	2,18%	Hisse senetleri
STATE STREET CORP	$1.883.049	366.352	2,16%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$1.182.200	230.000	1,35%	Hisse senetleri
UBS Group AG	$1.152.558	224.233	1,32%	Hisse senetleri
TUDOR INVESTMENT CORP ET AL	$1.057.216	205.684	1,21%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$768.476	149.509	0,88%	Hisse senetleri
MORGAN STANLEY	$745.182	144.977	0,85%	Hisse senetleri
Kestra Advisory Services, LLC	$680.536	132.400	0,78%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$680.526	132.398	0,78%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$662.829	128.955	0,76%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$659.866	127.971	0,76%	Hisse senetleri
NORTHERN TRUST CORP	$641.302	124.767	0,73%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$544.403	105.915	0,62%	Hisse senetleri
AQR CAPITAL MANAGEMENT LLC	$542.856	105.614	0,62%	Hisse senetleri
Cresset Asset Management, LLC	$533.784	103.849	0,61%	Hisse senetleri
AlphaQuest LLC	$502.645	70.795	0,58%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$500.168	97.309	0,57%	Hisse senetleri
Quantinno Capital Management LP	$423.192	82.333	0,48%	Hisse senetleri
CITADEL ADVISORS LLC	$406.127	79.013	0,47%	Hisse senetleri
Jump Financial, LLC	$398.350	77.500	0,46%	Hisse senetleri
Nuveen, LLC	$254.666	49.546	0,29%	Hisse senetleri
WOLVERINE TRADING, LLC	$228.312	29.346	0,26%	Hisse senetleri
ALLIANCEBERNSTEIN L.P.	$220.986	23.360	0,25%	Hisse senetleri
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$210.226	40.900	0,24%	Hisse senetleri
Bank of New York Mellon Corp	$198.641	38.646	0,23%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$181.946	35.398	0,21%	Hisse senetleri
Point72 Asset Management, L.P.	$137.613	26.773	0,16%	Hisse senetleri
XTX Topco Ltd	$112.181	21.825	0,13%	Hisse senetleri
JPMORGAN CHASE & CO	$109.932	18.507	0,13%	Hisse senetleri
Jain Global LLC	$109.482	21.300	0,13%	Hisse senetleri
Mitsubishi UFJ Asset Management Co., Ltd.	$106.532	20.726	0,12%	Hisse senetleri
RBF Capital, LLC	$102.800	20.000	0,12%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$102.085	19.861	0,12%	Hisse senetleri
RHUMBLINE ADVISERS	$96.688	18.812	0,11%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$85.797	16.692	0,10%	Hisse senetleri
Corton Capital Inc.	$85.461	10.590	0,10%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$84.476	16.435	0,10%	Hisse senetleri
Graham Capital Management, L.P.	$76.884	14.958	0,09%	Hisse senetleri
CWM, LLC	$76.238	8.059	0,09%	Hisse senetleri
JANE STREET GROUP, LLC	$69.390	13.500	0,08%	Alım opsiyonu
R Squared Ltd	$68.907	13.406	0,08%	Hisse senetleri

Tüm 95 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 4 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Chernett Jorey ×2 başvurular	02 Ekim 2026	0,62%	Değişiklik	·	SEC
New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell	20 Şubat 2025	7,80%	Değişiklik	·	SEC
Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 başvurular	06 Şubat 2025	4,90%	Değişiklik	·	SEC
New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 başvurular	07 Kasım 2024	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 25 içeriden öğrenenler · 11 yöneticiler · 9 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Alımlar 12ay	Satışlar 12ay	Net 12ay
Kevin Hykes	PRES & CEO	27 Şubat 2026 A	284.237	0	1	$-61.328
Nadim Yared	CHIEF EXECUTIVE OFFICER	02 Şubat 2024 A	26.255	0	0	$0
Jared Oasheim	CHIEF FINANCIAL OFFICER	27 Şubat 2026 A	96.703	0	1	$-13.778
Brent Binkowski	CHIEF OPERATING OFFICER	13 Ağustos 2026 P	56.514	1	1	$72.971
Philip B. Adamson	Chief Medical Officer	27 Şubat 2026 A	61.578	0	1	$-9.970
Robert Allen John	Chief Revenue Officer	27 Şubat 2026 A	86.036	0	1	$-31.316
Paul Verrastro	CHIEF MKTG & STRAT OFFICER	27 Şubat 2026 A	60.551	0	1	$-10.144
Craig E. Palmer	SVP, U.S. SALES	25 Mart 2024 M	1.229	0	0	$0
Liz Galle	VP OF GLOBAL CLINICAL RESEARCH	16 Ekim 2023 M	778	0	0	$0
Dean Bruhn-Ding	VP OF REG. AFFAIRS AND QA	02 Ağustos 2022 A	54.648	0	0	$0
John Brintnall	CHIEF STRATEGY OFFICER AND SEC	22 Nisan 2022 M	21.901	0	0	$0
Martha Shadan	Yönetim kurulu üyesi	01 Haziran 2026 A	8.720	0	0	$0
Mitch C. Hill,	Yönetim kurulu üyesi	01 Haziran 2026 A	8.720	0	0	$0
Mudit K. Jain	Yönetim kurulu üyesi	01 Haziran 2026 A	14.370	2	0	$300.432
Kevin J. Ballinger	Yönetim kurulu üyesi	01 Haziran 2026 A	8.720	0	0	$0
Kirk Nielsen	Yönetim kurulu üyesi	01 Haziran 2026 A	8.720	0	0	$0
Ali Behbahani	Yönetim kurulu üyesi	04 Haziran 2024 A	316	0	0	$0
John M Nehra	Yönetim kurulu üyesi	07 Haziran 2022 A	28.266	0	0	$0
Johnson & Johnson Innovation - JJDC, Inc.	10% sahip	15 Eylül 2023 J	0	0	0	$0
New Enterprise Associates 10, Limited Partnership	10% sahip	02 Temmuz 2021 C	2.026.083	0	0	$0
Joseph P Slattery	·	01 Haziran 2026 A	39.365	0	0	$0
DALE MICHAEL D	·	01 Haziran 2026 A	29.005	0	0	$0
Gregory Morrison	·	02 Mart 2026 A	34.000	0	0	$0
Geoffrey B Pardo	·	02 Temmuz 2021 C	1.829.022	0	0	$0
GSK plc	·	02 Temmuz 2021 C	1.007.583	0	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 14 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IWC · iShares Trust	0,01%	51.258 SH	11 Eylül 2026	Günlük
IWO · iShares Trust	0,00%	156.004 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,00%	7.352 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,00%	364.840 SH	11 Eylül 2026	Günlük
DFAS · Dimensional ETF Trust	0,00%	28.363 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	1.354 NS	31 Temmuz 2026	N-PORT
IWV · iShares Trust	0,00%	5.299 SH	03 Eylül 2026	Günlük
DFAC · Dimensional ETF Trust	0,00%	5.367 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	204.533 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	684.121 SH	19 Ağustos 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	89.003 SH	19 Ağustos 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,00%	15.722 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.190 SH	19 Ağustos 2026	Günlük
DXUV · Dimensional ETF Trust	0,00%	4 NS	31 Temmuz 2026	N-PORT

CVRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 13 analist AL

Medyan hedef $4.50 +190,3%

3 23,1% Güçlü Al

6 46,2% Al

3 23,1% Tut

1 7,7% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

6 analist · 2026-10-03

Ortalama hedef $4.58 +195,7%

← Tüm hedeflerin altında Mevcut fiyat $1.55

Düşük$3.50 Ortalama$4.58 Yüksek$6.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
CVRX	$187M	-3.5	10.4%	-94.1%	-109.6%	85.3%
MDAI	·	·	·	·	·	·
ODYS	$54M	-3.1	-23.9%	-565.0%	-58.7%	28.9%
SRTS	$66M	-8.5	-34.3%	-28.1%	-15.4%	43.2%
POCI	$56M	-11.9	65.2%	-11.5%	-24.5%	17.2%
SNWV	$256M	72.8	35.0%	26.8%	-395.5%	77.1%
QTI	$73M	-3.0	287.9%	-111.4%	-688.9%	45.4%
ARAY	$31M	-0.9	-12.3%	-12.2%	-103.4%	27.7%

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

CVRX CVRx, Inc. - Common Stock

CVRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

CVRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

CVRx, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Kurumsal Sahipler (13F) 95 dosya · $87.3M toplam · Tarih itibarıyla 30 Haziran 2026

Aktivistler ve %5+ sahipler 4 pozisyon

Şirket yöneticileri 25 içeriden öğrenenler · 11 yöneticiler · 9 yönetim kurulu üyeleri

ETF sahipliği 14 ETF'ler tarafından tutuluyor

CVRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar